Search Results - "Pye, Stephanie J"

  • Showing 1 - 7 results of 7
Refine Results
  1. 1

    Phase I Trial of a CD8+ T-Cell Peptide Epitope-Based Vaccine for Infectious Mononucleosis by ELLIOTT, Suzanne L, SUHRBIER, Andreas, COX, John, PYE, David, MOSS, Denis J, BHARADWAJ, Mandvi, MILES, John J, LAWRENCE, Greg, PYE, Stephanie J, LE, Thuy T, ROSENSTENGEL, Andrew, NGUYEN, Tam, ALLWORTH, Anthony, BURROWS, Scott R

    Published in Journal of Virology (01-02-2008)
    “…Article Usage Stats Services JVI Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley…”
    Get full text
    Journal Article
  2. 2

    Selection of a diverse TCR repertoire in response to an Epstein-Barr virus-encoded transactivator protein BZLF1 by CD8+ cytotoxic T lymphocytes during primary and persistent infection by Silins, S L, Cross, S M, Elliott, S L, Pye, S J, Burrows, J M, Moss, D J, Misko, I S

    Published in International immunology (01-11-1997)
    “…We investigated the CD8+ cytotoxic T lymphocyte (CTL) repertoire to an HLA B8-restricted peptide, RAKFKQLLQ, located in the Epstein-Barr virus (EBV)…”
    Get full text
    Journal Article
  3. 3

    An HLA-A2 Polyepitope Vaccine for Melanoma Immunotherapy by Mateo, Luis, Gardner, Joy, Chen, Qiyuan, Schmidt, Christopher, Down, Michelle, Elliott, Suzanne L, Pye, Stephanie J, Firat, Huseyin, Lemonnier, Francois A, Cebon, Jonathon, Suhrbier, Andreas

    Published in The Journal of immunology (1950) (01-10-1999)
    “…Epitope-based vaccination strategies designed to induce tumor-specific CD8 CTL are being widely considered for cancer immunotherapy. Here we describe a…”
    Get full text
    Journal Article
  4. 4
  5. 5

    Dominant Cytotoxic T Lymphocyte Response to the Immediate-Early Trans-Activator Protein, BZLF1, in Persistent Type A or B Epstein-Barr Virus Infection by Elliott, Suzanne L., Pye, Stephanie J., Schmidt, Chris, Cross, Simone M., Silins, Sharon L., Misko, Ihor S.

    Published in The Journal of infectious diseases (01-10-1997)
    “…Five healthy human leukocyte antigen-B8 (HLA-B8)-positive virus carriers were studied to investigate the CD8+ cytotoxic T lymphocyte (CTL) response to an…”
    Get full text
    Journal Article
  6. 6

    Phase I Trial of a CD8 super(+) T-Cell Peptide Epitope-Based Vaccine for Infectious Mononucleosis by Elliott, Suzanne L, Suhrbier, Andreas, Miles, John J, Lawrence, Greg, Pye, Stephanie J, Le, Thuy T, Rosenstengel, Andrew, Nguyen, Tam, Allworth, Anthony, Burrows, Scott R, Cox, John, Pye, David, Moss, Denis J, Bharadwaj, Mandvi

    Published in Journal of virology (01-02-2008)
    “…A single blind, randomized, placebo-controlled, single-center phase I clinical trial of a CD8 super(+) T-cell peptide epitope vaccine against infectious…”
    Get full text
    Journal Article
  7. 7

    Development of Epstein-Barr virus-specific memory T cell receptor clonotypes in acute infectious mononucleosis by Silins, S L, Cross, S M, Elliott, S L, Pye, S J, Burrows, S R, Burrows, J M, Moss, D J, Argaet, V P, Misko, I S

    Published in The Journal of experimental medicine (01-11-1996)
    “…The importance of cytotoxic T lymphocytes (CTLs) in the immunosurveillance of Epstein-Barr virus (EBV)-infected B cells is firmly established, and the viral…”
    Get full text
    Journal Article